SCHEMBL888325

SCHEMBL888325

c1ccc2c3c(ccc2c1)O[P]Oc1ccc2ccccc2c1-3

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.52
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 4/20 0.46
TSHR P16473 2/20 0.46
CYP2A6 P11509 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HPRT1 P00492 1/20 0.42
MAPT P10636 3/20 0.41
WDR5 P61964 1/20 0.39
HIF1A Q16665 1/20 0.39
CYP1B1 Q16678 1/20 0.39
KDM4E B2RXH2 4/20 0.39
CYP19A1 P11511 1/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
DNMT1 P26358 1/20 0.38
HPGD P15428 2/20 0.38
CES1 P23141 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8231432 0.74 GPR84 (0.52) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL5899656 0.74 GPR84 (0.52) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL9782961 0.74 GPR84 (0.52) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL11401769 0.72 GPR84 (0.50) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL3126921 0.72 GPR84 (0.50) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL24275937 0.71 GPR84 (0.53) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL17715388 0.71 GPR84 (0.49) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL21214530 0.71 GPR84 (0.49) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL22664856 0.71 GPR84 (0.53) GPR84ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL1777121 0.71 GPR84 (0.53) GPR84ALDH1A1HSD17B10TSHRCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073809-B2 Catalyst systems for the catalytic oligomerization of olefinic monomers SHELL OIL COMPANY (US) 2015-07-07 US disclosed
US-9073810-B2 Catalyst systems for the catalytic oligomerization of olefinic monomers SHELL OIL COMPANY (US) 2015-07-07 US disclosed
US-20140135551-A1 Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers SHELL OIL COMPANY (US) 2014-05-15 US disclosed
US-20140107304-A1 CATALYST SYSTEMS FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS SHELL OIL COMPANY (US) 2014-04-17 US disclosed
US-8680220-B2 Catalyst systems for the catalytic oligomerization of olefinic monomers SHELL OIL COMPANY (US) 2014-03-25 US disclosed
US-8637617-B2 Catalyst systems for the catalytic oligomerization of olefinic monomers SHELL OIL COMPANY (US) 2014-01-28 US disclosed
US-20110319579-A1 Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers SHELL OIL COMPANY (US) 2011-12-29 US disclosed
US-20110319577-A1 Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers SHELL OIL COMPANY (US) 2011-12-29 US disclosed
US-20110288356-A1 Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers SHELL OIL COMPANY (US) 2011-11-24 US disclosed
US-8022007-B2 Ligands and catalyst systems thereof for the catalytic oligomerization of olefinic monomers SHELL OIL COMPANY (US) 2011-09-20 US disclosed
US-20100317814-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS DE BOER ERIC JOHANNES MARIA 2010-12-16 US disclosed
US-20100311932-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS DE BOER ERIC JOHANNES MARIA 2010-12-09 US disclosed
US-20100311928-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS DE BOER ERIC JOHANNES MARIA 2010-12-09 US disclosed
US-20100311929-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS DE BOER ERIC JOHANNES MARIA 2010-12-09 US disclosed
US-7803886-B2 Ligands and catalyst systems thereof for the catalytic oligomerization of olefinic monomers SHELL OIL COMPANY (US) 2010-09-28 US disclosed
EP-2125845-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS Shell Internationale Research Maatschappij B.V. (NL) 2009-12-02 EP disclosed
US-20090062493-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS SHELL OIL COMPANY 2009-03-05 US disclosed
WO-2008077908-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062493-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS MSMO1, BPHL, CCNL2 GPR84 655/4885ALDH1A1 1490/4885HSD17B10 120/4885
US-20100311928-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS OXER1, NOD2, OPRM1 GPR84 1707/4885ALDH1A1 3895/4885HSD17B10 915/4885
US-20100317814-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS CCNL2, MSMO1, CBR1 GPR84 709/4885ALDH1A1 1643/4885HSD17B10 98/4885
US-20140135551-A1 Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers CCNL2, POR, INTS9 GPR84 1494/4885ALDH1A1 3054/4885HSD17B10 33/4885
US-20110319579-A1 Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers CCNL2, POR, INTS9 GPR84 1494/4885ALDH1A1 3054/4885HSD17B10 33/4885
US-20100311929-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS COG4, OXER1, RRS1 GPR84 594/4885ALDH1A1 3392/4885HSD17B10 1077/4885
US-20110288356-A1 Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers OXER1, CBR3, POR GPR84 1951/4885ALDH1A1 3864/4885HSD17B10 629/4885
US-20100311932-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS CDK20, INTS9, CCNL2 GPR84 969/4885ALDH1A1 2729/4885HSD17B10 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.